Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on: January 22,2024 11

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on:January 22,2024 11

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

Updated on: January 22,2024 18

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

Updated on:January 22,2024 18

Study links poverty to increased acute lymphoblastic leukemia relapse

by Brianna Hoge,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainA new study from the University of Alabama at Birmingham's Marnix E. Heersink School of Medicine suggests

Updated on: January 22,2024 11

Study links poverty to increased acute lymphoblastic leukemia relapse

by Brianna Hoge,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainA new study from the University of Alabama at Birmingham's Marnix E. Heersink School of Medicine suggests

Updated on:January 22,2024 11

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on: January 22,2024 17

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on:January 22,2024 17

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce

Updated on: January 22,2024 10

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce

Updated on:January 22,2024 10

Study illuminates precancerous 'clonal outgrowth' in blood cells

byWeill Cornell Medical CollegeCredit: CC0 Public DomainA common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may

Updated on: January 22,2024 20

Study illuminates precancerous 'clonal outgrowth' in blood cells

byWeill Cornell Medical CollegeCredit: CC0 Public DomainA common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may

Updated on:January 22,2024 20

Study examines hesitation toward potential changes to bowel cancer surveillance

byFlinders UniversityCredit: Pixabay/CC0 Public DomainAs doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new re

Updated on: January 22,2024 17

Study examines hesitation toward potential changes to bowel cancer surveillance

byFlinders UniversityCredit: Pixabay/CC0 Public DomainAs doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new re

Updated on:January 22,2024 17

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on: January 22,2024 11

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on:January 22,2024 11

Rethinking how cancer cells evade targeted therapy

byUniversity of California, San FranciscoA single-cell RNA atlas of human glioblastoma through recurrence.a, An overview of genomics studies on paired longitudinal GBM specimens.b, A

Updated on: January 22,2024 17

Rethinking how cancer cells evade targeted therapy

byUniversity of California, San FranciscoA single-cell RNA atlas of human glioblastoma through recurrence.a, An overview of genomics studies on paired longitudinal GBM specimens.b, A

Updated on:January 22,2024 17

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on: January 22,2024 15

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on:January 22,2024 15

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on: January 22,2024 17

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on:January 22,2024 17

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Updated on: January 22,2024 13

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Updated on:January 22,2024 13